Document is current

Any future updates will be listed below

Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial

Crossref DOI link: https://doi.org/10.1186/s12885-017-3774-7

Published Online: 2017-11-17

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark